Skip to main content
. 2020 Apr 10;9(1):1747332. doi: 10.1080/2162402X.2020.1747332

Figure 1.

Figure 1.

Identification of tumor-infiltrating IL-17A+ cells in muscle-invasive bladder cancer. (a) Representative immunochemistry staining of IL-17A+ cells in muscle-invasive bladder. (b) A fraction of patients with high/low IL-17A+ cells in different TNM stages. (c) The number of tumor-infiltrating IL-17A+ cells in different TNM stages. (d) Representative flow cytometry analysis of the surface markers expressed by IL-17A+ cells from fresh human muscle-invasive bladder cancer samples. (e) Quantification analysis of surface markers expressed by tumor-infiltrating IL-17A+ cells.